Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87451-87500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05362591
Anterior Resin Bonded Restorations for Adolescent
NAActive, not recruiting
24 participants
Started: May 8, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05134012
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
PHASE3Recruiting
215 participants
Started: May 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor13 locations
NCT05432648
Fiber Food Introduction in Pediatric Short Bowel Syndrome
NAActive, not recruiting
60 participants
Started: May 8, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05306457
CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS
PHASE1Active, not recruiting
16 participants
Started: May 8, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT05350891
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
PHASE2Recruiting
77 participants
Started: May 8, 2022 · Completed: May 8, 2026
1 condition2 sponsors8 locations
NCT06142370
The Prevalence of the Linburg-Comstock Variation
NAEnrolling by invitation
500 participants
Started: May 7, 2022 · Completed: May 10, 2025
1 condition2 sponsors1 location
NCT05068349
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
PHASE4Recruiting
300 participants
Started: May 7, 2022 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT05374252
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
PHASE3Recruiting
102 participants
Started: May 7, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06458114
Feeling of Caregivers After a Palliative Management of Extreme Premature Babies in Delivery Room.
N/ARecruiting
50 participants
Started: May 7, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05505487
Construction and Effect Evaluation of Integrated Care Model for Pulmonary Infection in Stroke Patients With Tracheotomy
NARecruiting
80 participants
Started: May 7, 2022 · Completed: May 7, 2026
2 conditions1 sponsor1 location
NCT05314023
Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)
PHASE3Active, not recruiting
1,590 participants
Started: May 7, 2022 · Completed: Feb 19, 2029
1 condition1 sponsor5 locations
NCT05294731
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
PHASE1/PHASE2Recruiting
146 participants
Started: May 6, 2022 · Completed: Sep 30, 2027
9 conditions1 sponsor29 locations
NCT06063278
Step by Step Group Therapy for Bulimia Nervosa: Effectiveness and Mechanisms of Change.
NARecruiting
100 participants
Started: May 6, 2022 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT06516406
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
N/ARecruiting
1,055 participants
Started: May 6, 2022 · Completed: May 31, 2032
3 conditions1 sponsor26 locations
NCT05801471
Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression
N/ARecruiting
200 participants
Started: May 6, 2022 · Completed: Nov 6, 2025
1 condition1 sponsor2 locations
NCT05405374
OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
NARecruiting
101 participants
Started: May 6, 2022 · Completed: Oct 31, 2025
5 conditions1 sponsor9 locations
NCT05155059
Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders
PHASE2Active, not recruiting
21 participants
Started: May 6, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT04976881
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
NARecruiting
840 participants
Started: May 6, 2022 · Completed: May 31, 2026
4 conditions3 sponsors1 location
NCT05285813
A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
PHASE2Active, not recruiting
42 participants
Started: May 6, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05368220
Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
N/AEnrolling by invitation
6,500 participants
Started: May 6, 2022 · Completed: May 31, 2027
2 conditions9 sponsors5 locations
NCT05759637
Type 2 Diabetes, Obesity and Cortisol Excess
N/ARecruiting
3,200 participants
Started: May 6, 2022 · Completed: Dec 6, 2025
3 conditions5 sponsors5 locations
NCT05310773
Couples Health CoOp Plus
NAActive, not recruiting
962 participants
Started: May 6, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT06404840
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
PHASE2Recruiting
30 participants
Started: May 6, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05516940
A Study of the Impact of Different Delivery Modes on Specific Macronutrient Components in Human Milk
N/AActive, not recruiting
250 participants
Started: May 6, 2022 · Completed: Jun 30, 2024
1 condition4 sponsors1 location
NCT05982925
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
N/AEnrolling by invitation
170 participants
Started: May 6, 2022 · Completed: Jul 31, 2034
3 conditions1 sponsor1 location
NCT05392088
Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study.
N/ARecruiting
1,500 participants
Started: May 6, 2022 · Completed: Aug 31, 2024
2 conditions1 sponsor1 location
NCT05348031
Multimodal Analysis of Structural Voice Disorders Based on Speech and Stroboscopic Laryngoscope Video
N/ANot yet recruiting
1 participants
Started: May 6, 2022 · Completed: Feb 20, 2027
1 condition2 sponsors0 locations
NCT05287867
Trial for Treating Painful Degenerative Disc Disease
NARecruiting
42 participants
Started: May 6, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT04818073
Determinants of the Effectiveness of Robot-assisted Hand Movement Training
NAActive, not recruiting
60 participants
Started: May 6, 2022 · Completed: Aug 31, 2025
2 conditions3 sponsors1 location
NCT05141513
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma
PHASE1Recruiting
25 participants
Started: May 6, 2022 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT05334277
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
PHASE2Recruiting
280 participants
Started: May 6, 2022 · Completed: Feb 29, 2028
1 condition3 sponsors26 locations
NCT04571203
Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment
PHASE1Enrolling by invitation
30 participants
Started: May 6, 2022 · Completed: Oct 1, 2029
1 condition1 sponsor1 location
NCT07204366
Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)
N/AActive, not recruiting
219 participants
Started: May 6, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT05303415
Study of Low-intensity Focused Ultrasound Effects on Heat Evoked fMRI Signals
NARecruiting
80 participants
Started: May 6, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04848064
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
PHASE1Recruiting
12 participants
Started: May 6, 2022 · Completed: Jan 30, 2026
4 conditions1 sponsor1 location
NCT05761470
Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation
PHASE2Recruiting
66 participants
Started: May 6, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT05436327
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
NAActive, not recruiting
479 participants
Started: May 6, 2022 · Completed: Jan 31, 2027
3 conditions2 sponsors1 location
NCT06195462
Effects of Laying on of Hands in Fibromyalgia
NARecruiting
72 participants
Started: May 6, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05264818
Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma
N/ARecruiting
100 participants
Started: May 6, 2022 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05408884
Miracle Messages Evaluation
NAActive, not recruiting
759 participants
Started: May 6, 2022 · Completed: Dec 15, 2024
1 condition2 sponsors1 location
NCT05310643
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
PHASE2Recruiting
30 participants
Started: May 5, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor9 locations
NCT00775476
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
PHASE2Recruiting
290 participants
Started: May 5, 2022 · Completed: Sep 30, 2028
1 condition9 sponsors8 locations
NCT06263920
Neurofrailty: A Study of Late-onset Epilepsy and Its Associations
N/ARecruiting
360 participants
Started: May 5, 2022 · Completed: Jan 12, 2027
3 conditions1 sponsor1 location
NCT05180825
Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy
PHASE2Recruiting
134 participants
Started: May 5, 2022 · Completed: Dec 1, 2031
3 conditions1 sponsor25 locations
NCT04960579
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
PHASE1Recruiting
231 participants
Started: May 5, 2022 · Completed: Dec 31, 2039
1 condition2 sponsors21 locations
NCT05301114
Social Risk Factors and Discrimination in Cancer Survivorship
NARecruiting
1,116 participants
Started: May 5, 2022 · Completed: Sep 30, 2026
5 conditions4 sponsors1 location
NCT05258305
AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast
NAActive, not recruiting
200 participants
Started: May 5, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor15 locations
NCT04289376
Quiet Eye Duration in Baseball
NAActive, not recruiting
21 participants
Started: May 5, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT04433351
Sensory-Motor Integration for Speech Rehabilitation in Patients with Post-stroke Aphasia
NARecruiting
36 participants
Started: May 5, 2022 · Completed: Mar 31, 2026
2 conditions3 sponsors1 location
NCT05385926
Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
PHASE2Recruiting
34 participants
Started: May 5, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location